Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Lanfear, David E ^a   Hasan, Reema ^b   Gupta, Ramesh C ^a   Williams, Celeste ^a   Czerska, Barbara ^a   Tita, Cristina ^a   Bazari, Rasha ^c   Sabbah, Hani N ^a  

^a HENRY FORD HOSPITAL   (United States)

^b PROVIDENCE HOSPITAL   (United States)

^c BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 6; MILRINONE; MYOGLOBIN; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CARDIOTONIC AGENT; TROPONIN I;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART OUTPUT; HUMAN; LUNG WEDGE PRESSURE; MALE; MYOCARDITIS; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; AGED; BLOOD; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; HOSPITALIZATION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NECROSIS; SOLUBILITY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; MIDDLE AGED; MILRINONE; NECROSIS; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949217869     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-67     Document Type: Article

References (19)

1. Cohn JN Goldstein SO Greenberg BH Lorell BH Bourge RC Jaski BE Gottlieb SO McGrew F 3rd DeMets DL White BG A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators N Engl J Med 1998, 339:1810-6. 10.1056/ NEJM199812173392503 9854116
2. Cuffe MS Califf RM Adams KF Jr Benza R Bourge R Colucci WS Massie BM O'Connor CM Pina I Quigg R Silver MA Gheorghiade M Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial Jama 2002, 287:1541-7. 10.1001/ jama.287.12.1541 11911756
3. Petersen JW Felker GM Inotropes in the management of acute heart failure Crit Care Med 2008, 36:S106-11. 10.1097/01.CCM.0000296273.72952.39 18158469
4. Levine B Kalman J Mayer L Fillit HM Packer M Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 1990, 323:236-41. 2195340
5. Tsutamoto T Hisanaga T Wada A Maeda K Ohnishi M Fukai D Mabuchi N Sawaki M Kinoshita M Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure J Am Coll Cardiol 1998, 31:391-8. 10.1016/ S0735-1097(97)00494-4 9462584
6. Okuyama M Yamaguchi S Nozaki N Yamaoka M Shirakabe M Tomoike H Serum levels of soluble form of Fas molecule in patients with congestive heart failure Am J Cardiol 1997, 79:1698-701. 10.1016/S0002-9149(97)00228-2 9202370
7. Yamaguchi S Yamaoka M Okuyama M Nitoube J Fukui A Shirakabe M Shirakawa K Nakamura N Tomoike H Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure Am J Cardiol 1999, 83:1500-1503. 10.1016/S0002-9149(99)00133-2 10335772
8. Parissis JT Venetsanou KF Mentzikof DG Ziras NG Kefalas CG Karas SM Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure Scand Cardiovasc J 1999, 33:344-50. 10.1080/ 14017439950141407 10622546
9. Paraskevaidis IA Parissis JT Th Kremastinos D Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: A novel mechanism of drug-induced improvement in contractile performance of the failing heart Curr Med Chem Cardiovasc Hematol Agents 2005, 3:243-7. 10.2174/1568016054368232 15974888
10. White M Ducharme A Ibrahim R Whittom L Lavoie J Guertin MC Racine N He Y Yao G Rouleau JL Schiffrin EL Touyz RM Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support Clin Sci (Lond) 2006, 110:483-9. 16402915
11. Milani RV Mehra MR Endres S Eigler A Cooper ES Lavie CJ Jr Ventura HO The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia Chest 1996, 110:992-5. 10.1378/chest.110.4.992 8874257
12. Adamopoulos S Parissis JT Iliodromitis EK Paraskevaidis I Tsiapras D Farmakis D Karatzas D Gheorghiade M Filippatos GS Kremastinos DT Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure Am J Cardiol 2006, 98:102-6. 10.1016/j.amjcard.2006.01.068 16784930
13. Kawamura A Yoshikawa T Takahashi T Hayashi T Takahashi E Anzai T Sato T Ogawa S Randomized trial of phosphodiesterase inhibitors versus catecholamines in patients with acutely decompensated heart failure Jpn Circ J 2001, 65:858-62. 10.1253/jcj.65.858 11665788
14. Sabbah HN Wang J Gupta RC Iisar I Viole T Brewer R Acute Left Ventricular Unloading in Dogs with Chronic Heart Failure: Continuous Aortic Flow Augmentation Versus Intra-Aortic Balloon Pumping J Card Fail 2009, 15(6):523-528. 19643364 10.1016/j.cardfail.2009.01.003
15. Felker GM Benza RL Chandler AB Leimberger JD Cuffe MS Califf RM Gheorghiade M O'Connor CM Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study J Am Coll Cardiol 2003, 41:997-1003. 10.1016/S0735-1097(02)02968-6 12651048
16. Matsumori A Shioi T Yamada T Matsui S Sasayama S Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure Circulation 1994, 89:955-8. 8124835
17. Endres S Sinha B Fulle HJ Amrinone suppresses the synthesis of tumor necrosis factor-alpha in human mononuclear cells Shock 1994, 1:377-80. 10.1097/00024382-199405000-00011 7743341
18. Francis GS Siegel RM Goldsmith SR Olivari MT Levine TB Cohn JN Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis Ann Intern Med 1985, 103:1-6. 2860833
19. Parissis JT Farmakis D Kremastinos DT Levosimendan therapy in decompensated chronic heart failure: Favourable haemodynamic and neurohormonal effects but for how long? Eur J Heart Fail 2006, 8:215. 10.1016/j.ejheart.2006.01.003 16442844